Colorado MEDtech, Inc. to Display Xanthon Xpression Analysis System at AACC Clinical Laboratory Exposition in Chicago.Business Editors/Health & Medical Writers BOULDER, Colo.--(BW HealthWire)--July 27, 2001 Colorado MEDtech, Inc. (Nasdaq:CMED CMED Coordinated Medical Emergency Direction CMED Central Massachusetts Emergency Dispatch ) announced today that its RELA division will be displaying the Xanthon Xpression Analysis System(TM) for demonstration purposes in its booth (no. 3333) at the 2001 American Association American Association refers to one of the following professional baseball leagues:
AACC American Association for Clinical Chemistry AACC American Association of Cereal Chemists AACC Anne Arundel Community College ) Annual Meeting and Clinical Laboratory Exposition to be held July 29 through August 2 at McCormick Place in Chicago, Illinois. The instrument is scheduled to be introduced to the market early next year for high-throughput gene expression analysis, and embodies a patented electrochemical electrochemical /elec·tro·chem·i·cal/ (-kem´i-k'l) pertaining to interaction or interconversion of chemical and electrical energies. e·lec·tro·chem·i·cal adj. detection technology for the direct analysis of DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. , RNA RNA: see nucleic acid. RNA in full ribonucleic acid One of the two main types of nucleic acid (the other being DNA), which functions in cellular protein synthesis in all living cells and replaces DNA as the carrier of genetic and proteins. RELA was originally selected as Xanthon's partner to develop the Xanthon instrument and is now preparing to manufacture the product for Xanthon. RELA, a division of Colorado MEDtech, provides electronic and electromechanical The use of electricity to run moving parts. Disk drives, printers and motors are examples. Electromechanical systems must be designed for the eventual deterioration of moving components that wear over time. The first TVs were electromechanical systems (see video/TV history). medical device and instrumentation development and manufacturing outsource services for in vitro in vitro /in vi·tro/ (in ve´tro) [L.] within a glass; observable in a test tube; in an artificial environment. in vi·tro adj. In an artificial environment outside a living organism. diagnostic, biotechnology and medical device original equipment manufacturers. "We are excited to be associated with Xanthon and demonstrate their technology and our product development and manufacturing capabilities at the AACC show," said Stephen K. Onody, Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Colorado MEDtech. "The world of in vitro diagnostics In vitro diagnostic (IVD) tests are medical tests conducted in a test tube, or more generally in a controlled environment outside a living organism. In vitro means in glass in Latin. and biotechnology continues to converge, and this is a great opportunity to display this technology." Xanthon is a bioinformation solutions company created to commercialize its patented electrochemical detection technology for the direct analysis of DNA, RNA and proteins. Xanthon has announced that its first products are scheduled to be released early next year for high-throughput expression analysis applications in pharmaceutical companies for drug discovery. Xanthon has announced that future products will include the Xanthon SNP SNP Scottish National Party Noun 1. SNP - (genetics) genetic variation in a DNA sequence that occurs when a single nucleotide in a genome is altered; SNPs are usually considered to be point mutations that have been evolutionarily Analysis System(TM) and the Xanthon Proteomics Analysis System(TM). Colorado MEDtech, Inc. is a leading full-service OneSource OutSource(TM) provider of advanced medical technology outsourcing services, including device and disposables development software, medical device connectivity, manufacturing, critical system components for medical imaging and ultrasound accessories. Forward-Looking Statements The statements in this news release regarding the Company's plans to display the Xanthon Xpression Analysis System(TM), the scheduled market introduction of the instrument, and Xanthon's scheduled release of its first products are forward-looking statements that represent management's beliefs and assumptions based on currently available information. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it cannot assure that these expectations will prove to be correct. Such statements involve risks and uncertainties, including, but not limited to, the risk that unanticipated engineering or manufacturing difficulties may hamper development, manufacturing or release of the Xanthon Xpression Analysis System, the risk that Xanthon's first products will not be released within the schedule anticipated by Xanthon, the risk that future Xanthon products identified in this release will not be successfully developed, produced or sold, the risk that a downturn in general economic conditions or customer budgets may adversely affect research and development and capital expenditure budgets of potential customers upon which the Company is dependent, the risks associated with regulation by the Federal Food and Drug Administration, including compliance with the Quality System Regulation, and other factors as are more fully described in the Company's documents that are filed from time to time with the Securities and Exchange Commission. Should one or more of these risks materialize (or the consequences of such a development worsen), or should the underlying assumptions prove incorrect, actual results could differ materially from those forecasted or expected. The Company disclaims any intention or obligation to update publicly or revise any forward-looking statements whether as a result of new information, future events or otherwise. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion